Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Reproductive Health Market Research

Middle East And Africa Male Infertility Market 2023-2030

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 102 Pages Triton Market Research July, 2023 TRTN18073116
Best Price Guarantee
Price from $1,500
Length 102 Pages
Publisher Triton Market Research
Published Date July, 2023
SKU TRTN18073116

Middle East And Africa Male Infertility Market 2023-2030



MARKET OUTLOOK

Triton Market Research’s report insinuates that the male infertility market in the Middle East and Africa is anticipated to advance in value at a compound annual growth rate of 5.02% during the forecast years 2023-2030. South Africa, Turkey, Saudi Arabia, the UAE, and Rest of Middle East & Africa are taken into consideration in the region.

In the UAE, a decline in fertility rates, expansion of fertility centers and clinics, and supportive government policies are among the major factors expected to contribute to the growth of male infertility. For instance, the fertility rate has declined by 0.94% since 2021. Further, the country witnessed an expansion of fertility centers and clinics specializing in different treatments. Therefore, as stated above, these factors support the expansion of the male infertility market.

Furthermore, in Turkey, the market is expected to witness substantial growth on account of the rising prevalence of diseases reducing fertility rates and medical tourism. According to industry sources, the number of people diagnosed with diabetes is expected to rise to 10.8 billion by 2030. Such a substantial increase in diabetes prevalence is likely to have a negative impact on male fertility rates, thereby elevating the demand for infertility treatments.

COMPETITIVE OUTLOOK

The notable companies in the male infertility market consist of Vitrolife, Halotech DNA, Endo International Plc, EMD Serono Inc, and Bayer AG.


1. Middle East And Africa Male Infertility Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Male Infertility Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Mergers & Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. Prevalence Of Infertility
2.6.2. Use Of Assisted Reproductive Technologies
2.6.3. Technological Innovations And Advancements
2.7. Market Challenge
2.7.1. High Cost Of Treatment
2.8. Market Opportunities
2.8.1. Increasing Acceptance Of Minimally Invasive Surgeries
2.8.2. Growing Availability Of Infertility Treatment Drugs, Procedures, And Devices
2.8.3. Government Initiatives Toward Improving Reimbursement Policies
2.9. Analyst Perspective
3. Middle East And Africa Male Infertility Market – By Test Type
3.1. Dna Fragmentation Technique
3.2. Oxidative Stress Analysis
3.3. Microscopic Examination
3.4. Sperm Agglutination
3.5. Computer-assisted Semen Analysis
3.6. Sperm Penetration Assay
3.7. Other Test Types
4. Middle East And Africa Male Infertility Market – By Treatment
4.1. Assisted Reproductive Technology And Surgery
4.2. Medications
5. Middle East And Africa Male Infertility Market – By Country Outlook
5.1. Country Analysis
5.1.1. United Arab Emirates
5.1.1.1. United Arab Emirates Male Infertility Market Forecast & Prospects
5.1.2. Turkey
5.1.2.1. Turkey Male Infertility Market Forecast & Prospects
5.1.3. Saudi Arabia
5.1.3.1. Saudi Arabia Male Infertility Market Forecast & Prospects
5.1.4. South Africa
5.1.4.1. South Africa Male Infertility Market Forecast & Prospects
5.1.5. Rest Of Middle East & Africa
5.1.5.1. Rest Of Middle East & Africa Male Infertility Market Forecast & Prospects
6. Competitive Landscape
6.1. Halotech Dna
6.1.1. Overview
6.1.2. Product Portfolio
6.2. Emd Serono Inc
6.2.1. Overview
6.2.2. Product Portfolio
6.2.3. Key Strengths
6.2.4. Key Challenges
6.3. Endo International Plc
6.3.1. Overview
6.3.2. Product Portfolio
6.3.3. Key Strengths
6.3.4. Key Challenges
6.4. Vitrolife
6.4.1. Overview
6.4.2. Product Portfolio
6.4.3. Key Strengths
6.4.4. Key Challenges
6.5. Bayer Ag
6.5.1. Overview
6.5.2. Product Portfolio
6.5.3. Key Strengths
6.5.4. Key Challenges
6.6. Aytu Biopharma
6.6.1. Overview
6.6.2. Product Portfolio
6.6.3. Key Strengths
6.6.4. Key Challenges
6.7. Zydus Lifesciences Limited
6.7.1. Overview
6.7.2. Product Portfolio
6.7.3. Key Strengths
6.7.4. Key Challenges
6.8. Cinnagen Co
6.8.1. Overview
6.8.2. Product Portfolio
6.8.3. Key Strengths
6.8.4. Key Challenges
6.9. Sanofi Sa
6.9.1. Overview
6.9.2. Product Portfolio
6.9.3. Key Strengths
6.9.4. Key Challenges
6.10. Laboratory Corporation Of America Holdings
6.10.1. Overview
6.10.2. Product Portfolio
6.10.3. Key Strengths
6.10.4. Key Challenges
7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources Of Data
7.3. Research Methodology
Table List
Table 1: Middle East And Africa Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 2: List Of Collaborations
Table 3: List Of Product Launches
Table 4: List Of Mergers & Acquisitions
Table 5: List Of Business Divestitures & Expansions
Table 6: Middle East And Africa Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 7: Middle East And Africa Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 8: Middle East And Africa Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Figure List
Figure 1: Market Maturity Analysis
Figure 2: Middle East And Africa Male Infertility Market, By Type, 2022 & 2030 (In %)
Figure 3: Middle East And Africa Male Infertility Market, By Dna Fragmentation Technique, 2023-2030 (In $ Million)
Figure 4: Middle East And Africa Male Infertility Market, By Oxidative Stress Analysis, 2023-2030 (In $ Million)
Figure 5: Middle East And Africa Male Infertility Market, By Microscopic Examination, 2023-2030 (In $ Million)
Figure 6: Middle East And Africa Male Infertility Market, By Sperm Agglutination, 2023-2030 (In $ Million)
Figure 7: Middle East And Africa Male Infertility Market, By Computer-assisted Semen Analysis, 2023-2030 (In $ Million)
Figure 8: Middle East And Africa Male Infertility Market, By Sperm Penetration Assay, 2023-2030 (In $ Million)
Figure 9: Middle East And Africa Male Infertility Market, By Other Test Types, 2023-2030 (In $ Million)
Figure 10: Middle East And Africa Male Infertility Market, By Treatment, 2022 & 2030 (In %)
Figure 11: Middle East And Africa Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2030 (In $ Million)
Figure 12: Middle East And Africa Male Infertility Market, By Medications, 2023-2030 (In $ Million)
Figure 13: Middle East And Africa Male Infertility Market, By Country Outlook, 2022 & 2030 (In %)
Figure 14: United Arab Emirates Male Infertility Market 2023-2030 (In $ Million)
Figure 15: Turkey Male Infertility Market 2023-2030 (In $ Million)
Figure 16: Saudi Arabia Male Infertility Market 2023-2030 (In $ Million)
Figure 17: South Africa Male Infertility Market 2023-2030 (In $ Million)
Figure 18: Rest Of Middle East & Africa Male Infertility Market 2023-2030 (In $ Million)

$1,500
$2,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings